About Agen Genomics
Agen Genomics is a private company based in Escondido, California, incorporated in 2025 in California. It has reported $25,000 raised in one offering on Form D since September 2026. Its chief executive is Christopher Lippe.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 28, 2026 | Sep 2, 2026 | $25,000of $1.5M target | 0 | — | EquityRule 506(b) | Form D ↗ |
The filing for the offering first filed Sep 2, 2026 reports amount sold with no investors. Figures are shown as filed.
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Agen Genomics's Form D filed Sep 2, 2026.
